Drugs / Ledipasvir/sofosbuvir
last change Sep 2019 re-read 2 minutes ago

Ledipasvir/sofosbuvir

Developed for
hepatitis C virus infection
Investigated by
Assiut University

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT03169348 Nov 2017 → Jun 2019 hepatitis C virus infection Assiut University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ledipasvir/sofosbuvir ClinicalTrials.gov intervention name — accepted as the source's own label NCT03169348